CRANIOFACIAL SKELETAL TISSUE ENGINEERING CONFERENCE

描述（由申请人提供）：本申请是一系列两年一次会议中的第二次会议，其总体目标是促进颅面科学和相关卫生保健领域的重要进展。该系列专题讨论会的具体目的是：(1)促进来自学术界、工业界和私人执业的临床医生、教育工作者和研究人员之间的协作互动；(2)加强新技术向临床实践的转化；(3)为学术和行业研究人员提供临床相关领域的见解，以关注未来的发展；(4)教育学生并为年轻研究者提供机会；(5)建立专题讨论会系列，作为展示和讨论颅面科学前沿发展的论坛。每次专题讨论会都侧重于一个特定的专题领域。2002年9月，NIDCR支持的首届研讨会“21世纪颅面成像”在加利福尼亚州太平洋格罗夫的Asilomar会议中心举行，取得了巨大成功。下一届“颅面骨骼生物工程”研讨会将于2004年8月27日至30日在同一地点举行。由于近年来生物工程组织的快速发展及其在颅面结构修复中的巨大应用潜力，这一主题既相关又及时。本次研讨会的目标是将生物工程基础、转化和临床方面的专家聚集在一起，发表论文和海报，参加讲座和小组讨论，并提出有助于推动该领域向前发展的概念。本次研讨会的具体目标是：(1)传播信息并讨论骨骼生物工程在以下领域的现状：(a)细胞和支架；(b)机械诱导和生物活性剂；(c)骨和软骨生物工程；(d)开发复杂的生物工程结构，如牙齿、关节和牙周组织。(2)识别、优先考虑和讨论与生物工程组织临床应用相关的挑战，并制定临床方案，使这些技术得到最佳利用。(3)通过出版的论文集传播专题讨论会的发言。来自学术界和临床实践的广泛合格演讲者已被选中，以确保高水平，智力挑战和富有成效的会议。会议将限制250名具有生物工程背景的与会者。

DESCRIPTION (provided by applicant): This application is for the second in a series of biennial conferences whose overall objective is to enhance advances in areas of importance to craniofacial sciences and related health care. The specific aims of this symposia series are to: (1) foster collaborative interactions among clinicians, educators and researchers from academics, industry and private practice; (2) enhance the transfer of novel technologies into clinical practice; (3) provide academic and industry researchers insights into clinically relevant areas in which to focus future developments; (4) educate students and provide opportunities for young investigators and (5) establish the symposia series as a forum for presentation and discussion of cutting-edge developments in craniofacial sciences. Each symposium focuses on a specific thematic area. The highly successful NIDCR supported inaugural symposium titled "Craniofacial Imaging in the 21st Century" was held in September 2002 at Asilomar Conference Center in Pacific Grove, California. The next symposium titled "Craniofacial Skeletal Bioengineering" will be held from August 27 to 30, 2004 at the same venue. Because of the recent rapid advances in bioengineered tissues and their tremendous potential for application to restoration of craniofacial structures, this topic is both relevant and timely. The objective for the proposed symposium is to bring together experts in basic, translational and clinical aspects of bioengineering to present papers and posters, to participate in lectures and small group discussions and propose concepts that will help drive this field forward. The specific goals of this symposium are to: (1) Disseminate information and discuss the current status of skeletal bioengineering in the areas of (a) cells and scaffolds, (b) mechanoinducitve and bioactive agents, (c) bioengineering bone and cartilage and (d) developing complex bioengineered structures such as teeth, joints and periodontium. (2) Identify, prioritize and discuss challenges related to clinical applications of bioengineered tissues and develop clinical protocols that will enable the optimum utilization of these technologies. (3) Disseminate symposium presentations by published proceedings. A broad spectrum of well qualified speakers from academics and clinical practice have been selected to ensure a high caliber, intellectually challenging and productive meeting. The meeting will be limited to 250 participants who have a background in bioengineering.